Mantle cell lymphoma other diagnostic studies

Revision as of 13:20, 21 September 2012 by Kalsang Dolma (talk | contribs)
Jump to navigation Jump to search

Mantle cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mantle cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mantle cell lymphoma other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mantle cell lymphoma other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mantle cell lymphoma other diagnostic studies

on Mantle cell lymphoma other diagnostic studies

Mantle cell lymphoma other diagnostic studies in the news

Blogs on Mantle cell lymphoma other diagnostic studies

Directions to Hospitals Treating Mantle cell lymphoma

Risk calculators and risk factors for Mantle cell lymphoma other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Other Diagnostic Studies

FISH

Diagnosis generally requires stained slides of a surgically removed part of a lymph node. Other methods are also commonly used, including cytogenetics and fluorescence in situ hybridization (FISH).

PCR

Polymerase chain reaction (PCR) and CER3 clonotypic primers are additional methods, but are less often used.

Immunophenotype

The immunophenotype profile consists of CD5+ (in about 80%)[1], CD10-/+, CD20+, CD23+/-, CD23-/+ (though plus in rare cases). Generally cyclin D1 is expressed but it may not be required. The workup for Mantle cell lymphoma is similar to the workup for many indolent lymphomas and certain aggressive lymphomas.

Bone Marrow Aspiration

Mantle cell lymphoma is a systemic disease with frequent involvement of the bone marrow and gastrointestinal tract (generally showingpolyposis in the lining). There is also a not-uncommon leukemic phase, marked by presence in the blood. For this reason, both the peripheral blood and bone marrow are evaluated for the presence of malignant cells.

Lumbar Puncture

In some patients with the blastic variant, lumbar puncture is done to evaluate the spinal fluid for involvement.

References

  1. Stanford School of Medicine: "Mantle Cell Lymphoma, Differential Diagnosis" [1]

Template:Hematology

Template:WH Template:WS